14 results on '"Sunish IP"'
Search Results
2. Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole.
- Author
-
Sunish IP, Rajendran R, Munirathinam A, Kalimuthu M, Kumar VA, Nagaraj J, and Tyagi BK
- Subjects
- Animals, Child, Drug Administration Schedule, Elephantiasis, Filarial epidemiology, Elephantiasis, Filarial parasitology, Female, Helminthiasis epidemiology, Helminthiasis parasitology, Helminths drug effects, Helminths pathogenicity, Humans, Intestinal Diseases, Parasitic epidemiology, Intestinal Diseases, Parasitic parasitology, Male, Albendazole administration & dosage, Diethylcarbamazine administration & dosage, Elephantiasis, Filarial drug therapy, Helminthiasis drug therapy, Intestinal Diseases, Parasitic drug therapy
- Abstract
Background & Objectives: One third of the world's population is infected with one or more of the most common soil-transmitted helminths (STH). Albendazole (ALB) is being administered with diethyl carbamazine (DEC) in filariasis endemic areas to eliminate lymphatic filariasis (LF) and helminth infections. In this study, the cumulative impact of seven annual rounds of mass drug administrations (MDA) of DEC and ALB on STH infection in school children in selected villages in southern India was determined., Methods: During 2001-2010, seven MDAs were implemented by the Tamil Nadu s0 tate h0 ealth d0 epartment, India. LF and STH infections were monitored in school children from 18 villages of the two treatment arms (viz, DEC alone and DEC+ALB). Kato-Katz cellophane quantitative thick smear technique was employed to estimate STH infections at three weeks, six months and one year post MDA., Results: Prior to treatment, an overall STH prevalence was 60 per cent. After each MDA, infection markedly reduced at three weeks post-treatment in both the arms. The prevalence increased at six months period, which was maintained up to one year. After seven rounds of MDA, the infection reduced from 60.44 to 12.48 per cent in DEC+ALB arm; while the reduction was negligible in DEC alone arm (58.77 to 52.70%)., Interpretation & Conclusions: Seven rounds of MDA with DEC+ALB reduced the infection load significantly, and further sustained low level of infection for 10 years. However, complete parasite elimination could not be achieved. To curtail STH infection in the community, MDA should be regularized and environmental sanitation measures need to be improved by effective community-based campaigns.
- Published
- 2015
- Full Text
- View/download PDF
3. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
- Author
-
Sunish IP, Kalimuthu M, Rajendran R, Munirathinam A, Ashok Kumar V, Nagaraj J, and Tyagi BK
- Subjects
- Albendazole therapeutic use, Animals, Culex parasitology, Diethylcarbamazine therapeutic use, Disease Eradication, Drug Administration Schedule, Drug Therapy, Combination, Elephantiasis, Filarial prevention & control, Filaricides therapeutic use, Humans, India epidemiology, Insect Vectors parasitology, Longitudinal Studies, Treatment Outcome, Albendazole administration & dosage, Diethylcarbamazine administration & dosage, Elephantiasis, Filarial drug therapy, Elephantiasis, Filarial transmission, Filaricides administration & dosage
- Abstract
The National Programme for the Elimination of Lymphatic Filariasis is underway in the endemic districts of Tamil Nadu State, South India, since 2001. Annual mass drug administration (MDA) was carried out by the state health department to all eligible individuals. The impact of MDAs on transmission parameters was evaluated in 2 revenue blocks, viz, one with DEC alone and the other with a combination of albendazole. After 10 years with 6 annual MDAs, the transmission indices reached low levels in both treatment arms, but still persisted. However, the DEC alone arm showed higher transmission rates, compared to the DEC+ALB arm. Few villages which demonstrated persistent transmission need to be targeted with an additional control measure viz, vector control, to achieve LF elimination. It is evident from the 10 year period of the study that inclusion of albendazole along with DEC has significantly reduced the transmission indices to almost nil level, as compared to DEC alone., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
4. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
- Author
-
Sunish IP, Munirathinam A, Kalimuthu M, Ashok Kumar V, and Tyagi BK
- Subjects
- Animals, Antigens, Helminth blood, Child, Child, Preschool, Diethylcarbamazine therapeutic use, Drug Administration Schedule, Drug Therapy, Combination, Filaricides therapeutic use, Humans, Incidence, India epidemiology, Medication Adherence, Prevalence, Rural Population, Treatment Outcome, Albendazole therapeutic use, Diethylcarbamazine administration & dosage, Elephantiasis, Filarial drug therapy, Filaricides administration & dosage, Wuchereria bancrofti drug effects
- Abstract
Under the Global Programme to Eliminate Lymphatic Filariasis (LF), mass drug administration (MDA) is being implemented in Tamil Nadu, south India, by the State health machinery. The impact of six annual rounds of MDA using diethylcarbamazine (DEC) with and without albendazole (ALB) on filarial infection (microfilaraemia prevalence-MFP; antigenaemia prevalence-AGP) in paediatric population of 2-9 years was determined in two revenue blocks, with a population of 321 000. After each MDA, 300-400 children were screened for filarial infection. After six MDAs, an overall MFP reduction of 84.67% and 57.95% was observed in DEC+ALB and DEC alone arms, respectively. Corresponding AGP reductions were 72.88% (p < 0.001) and 41.51% (p = 0.023). Observation of microfilaraemic children after six MDAs (0.32% in DEC+ALB; 0.75% in DEC alone), necessitates the need for supplementary control strategies (viz., vector control), in order to achieve the goal of LF elimination., (© The Author [2013]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
5. Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.
- Author
-
Sunish IP, Shriram AN, Sivan A, Kartick C, Saha BP, and Vijayachari P
- Subjects
- Adult, Animals, Elephantiasis, Filarial prevention & control, Humans, India, Wuchereria bancrofti, Albendazole administration & dosage, Elephantiasis, Filarial drug therapy, Filaricides administration & dosage, Medication Adherence statistics & numerical data
- Abstract
Lymphatic filariasis (LF) is endemic in the Andaman and Nicobar islands, including the lone foci for a diurnally sub-periodic form of Wuchereria bancrofti in the Nancowry group of islands. A programme to eliminate LF was launched in 2004 by the Directorate of Health Services, Andaman and Nicobar Administration which involved a single annual mass drug administration (MDA) using diethylcarbamazine (DEC) with albendazole. So far, eight rounds of MDA have been implemented through the Public Health Care network. The pattern of antifilarial drug distribution and compliance achieved in the on-going LF elimination programme in these islands has been assessed. This is the first systematic effort undertaken in these remote islands to assess the coverage and compliance with the LF elimination programme. This study covered 900 households in each of the 3 districts. There were a largest number of side effects in the Nicobar district (6.4%). Non-consumption of drugs ranged from 18.6% (Nicobar) to 42% (North and Middle Andaman). A survey revealed that almost 95.3% of the respondents had heard about MDA from the drug distributors. Therefore, the distributors should be involved in programmes designed to educate the community at risk of acquiring filarial infection and the possible side effects of the drugs.
- Published
- 2013
- Full Text
- View/download PDF
6. Impact of ivermectin drug combinations on Pediculus humanus capitis infestation in primary schoolchildren of south Indian rural villages.
- Author
-
Munirathinam A, Sunish IP, Rajendran R, and Tyagi BK
- Subjects
- Administration, Oral, Animals, Anthelmintics therapeutic use, Child, Drug Therapy, Combination, Endemic Diseases statistics & numerical data, Filaricides therapeutic use, Humans, India, Lice Infestations epidemiology, Lice Infestations prevention & control, Pediculus, Prevalence, Rural Population statistics & numerical data, Albendazole therapeutic use, Antiparasitic Agents therapeutic use, Diethylcarbamazine therapeutic use, Ivermectin therapeutic use, Lice Infestations drug therapy
- Abstract
Background: Antifilarial drug combinations including ivermectin provide antifilarial activity with ancillary benefits on intestinal helminths and ectoparasites, such as chiggers and lice. The impact of single oral dose of antifilarial drugs, viz; (1) diethylcarbamazine (DEC) alone, (ii) DEC + albendazole (ALB), (iii) ivermectin (IVR) + DEC and (iv) IVR + ALB, was determined, on the head louse (Pediculus humanus capitis) in primary school children in a rural community in south India., Methods: Primary school children (n = 534) of age 6-10 years from four villages of South India were examined for the presence of head lice before and after single dose of DEC + ivermectin drug combination. The effectiveness and the duration of cure sustained by these drugs were quantified. The head louse was examined by "combing method" during post-treatment periods at 15, 45, 60 and 75 days interval., Results: The antifilarial drug consumption rate was similar (96-98%) in all treatment arms. In pre-treatment survey the prevalence of head lice in children administered with DEC, DEC + ALB, IVR + DEC and IVR + ALB arm was 86%, 80%, 87% and 80%, respectively, with the latter two arms demonstrating significant reduction in louse infestation (P < 0.05) for 60 days., Conclusion: Single dose with IVR combination demonstrates a greater impact in reducing head louse infestation in the endemic rural communities for nearly 60 days. Therefore, in regions such as Africa where ivermectin is part of the antifilariasis campaign, this drug will have an additional benefit in reducing head lice infestation.
- Published
- 2009
- Full Text
- View/download PDF
7. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
- Author
-
Rajendran R, Sunish IP, Mani TR, Munirathinam A, Arunachalam N, Satyanarayana K, and Dash AP
- Subjects
- Adolescent, Adult, Animals, Antigens, Helminth blood, Child, Child, Preschool, Culex parasitology, Drug Therapy, Combination, Elephantiasis, Filarial epidemiology, Elephantiasis, Filarial transmission, Endemic Diseases prevention & control, Female, Filaricides therapeutic use, Humans, India epidemiology, Insect Vectors parasitology, Longitudinal Studies, Male, Patient Compliance, Rural Health, Soil parasitology, Treatment Outcome, Albendazole therapeutic use, Anthelmintics therapeutic use, Diethylcarbamazine therapeutic use, Elephantiasis, Filarial drug therapy
- Abstract
As part of the Global Programme for Elimination of Lymphatic Filariasis (GPELF), India is implementing mass drug administration (MDA) with annual single dose of diethylcarbamazine (DEC) with and without albendazole (ALB). The impact of MDAs on filarial infections and soil-transmitted helminth (STH) infections was assessed during a 3-year period in two communities, one with DEC + ALB and the other with DEC alone. Prior to each MDA (during 2001, 2002 and 2003), filarial indices (microfilaraemia and antigenaemia) were assessed from blood samples of 450-650 persons aged 2-25 years and STH infections in stool samples (Kato-Katz method) from 325 to 500 children aged 9-10 years. Mosquitoes resting indoors were collected to determine the filarial infection status. The microfilaraemia prevalence decreased significantly (P < 0.05) in both arms, with the highest decline in the DEC + ALB arm (72%vs. 51%). Decline in micrefilaria intensity was also higher in the DEC + ALB arm (81.4%vs. 48.5%). In this arm alone, the antigenaemia prevalence was reduced significantly (62%; P < 0.001). The reduction in STH prevalence was lower in the DEC alone arm (6.5%; NS) than in the DEC + ALB arm (70.9%; P < 0.001). Also, the egg reduction in DEC alone arm was only half that of DEC + ALB arm (49%vs. 97%). Our community-based follow-up study showed higher and sustained benefits with regard to filarial and STH infections for the two-drug arm over the DEC alone arm. The trends suggest that at least 10 MDAs may be necessary to achieve the goal of elimination.
- Published
- 2006
- Full Text
- View/download PDF
8. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
- Author
-
Sunish IP, Rajendran R, Mani TR, Dash AP, and Tyagi BK
- Subjects
- Adolescent, Adult, Albendazole administration & dosage, Child, Clinical Trials as Topic, Diethylcarbamazine administration & dosage, Diethylcarbamazine therapeutic use, Drug Therapy, Combination, Filaricides administration & dosage, Humans, India, Albendazole therapeutic use, Elephantiasis, Filarial drug therapy, Filaricides therapeutic use
- Published
- 2006
- Full Text
- View/download PDF
9. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
- Author
-
Mani TR, Rajendran R, Sunish IP, Munirathinam A, Arunachalam N, Satyanarayana K, and Dash AP
- Subjects
- Child, Cross-Sectional Studies, Drug Therapy, Combination, Elephantiasis, Filarial epidemiology, Helminthiasis epidemiology, Humans, India epidemiology, Infant, Prevalence, Treatment Outcome, Albendazole administration & dosage, Anthelmintics administration & dosage, Diethylcarbamazine administration & dosage, Elephantiasis, Filarial prevention & control, Helminthiasis prevention & control
- Abstract
A longitudinal community-trial on the control of soil-transmitted helminths (STHs), as part of a lymphatic filariasis elimination campaign, was taken up in two revenue blocks of southern India in the years 2001 and 2002 to assess the impact of two annual single-dose mass drug administration (MDA) of diethylcarbamazine (DEC) + albendazole (ALB) with that of DEC alone. The prevalences and intensities of STHs were studied among cross-sectional samples of school children aged 9-10 years by using the Kato-Katz technique at baseline and 11 months after each MDA. The combined drug mass treatment produced a higher reduction in the prevalence (RIP) (51-77%) and the egg reduction rate (ERR) (92-98%) compared with 12-15% RIP and 58-62% ERR of DEC alone mass treatment. The effect of two-drug therapy after two annual treatments was relatively long lasting as shown by RIP and ERR indicating that the reinfection rates were relatively lower in this approach than single-drug therapy. This study demonstrates that mass drug co-administration of DEC + ALB in Global Programme for Elimination of Lymphatic Filariasis (GPELF) targeted at the community had a synergistic and sustainable effect against soil-transmitted helminthiasis and provided considerable 'beyond filariasis' benefits. The additional advantages accrued to the community underscore the importance of scaling-up GPELF to cover the entire population at risk.
- Published
- 2004
- Full Text
- View/download PDF
10. Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India.
- Author
-
Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Arunachalam N, and Satyanarayana K
- Subjects
- Adolescent, Adult, Animals, Antigens, Helminth blood, Child, Child, Preschool, Cross-Sectional Studies, Drug Administration Schedule, Drug Therapy, Combination, Humans, Patient Compliance, Treatment Outcome, Wuchereria bancrofti, Albendazole administration & dosage, Anthelmintics administration & dosage, Diethylcarbamazine administration & dosage, Elephantiasis, Filarial prevention & control
- Abstract
A two-arm community-based lymphatic filariasis elimination trial is being carried out in Tamil Nadu state, India to assess the effect of 2 annual single-dose mass drug administrations of diethylcarbamazine + albendazole (DEC + ALB) on microfilaraemia and antigenaemia in one arm, and diethylcarbamazine(DEC) alone in the other arm. In a cross-sectional survey at each time-point, 450-650 subjects in childhood (2-9 years old) and young adulthood (10-25 years old) were screened from each treatment arm. After 2 annual mass drug administrations, microfilaraemia prevalence in the 2-drug arm was reduced by 54% and 62% in the 2-9 year old and 10-25 year old groups respectively; and corresponding figures for the single-drug arm were 26% and 37%. Though higher reductions were recorded for geometric mean intensity of microfilaraemia in the 2-9 year old groups for both treatment arms, reduction was more pronounced in the 2-drug arm than the single drug arm (74% vs. 24%) in the 10-25 year old group. The reduction in the antigenaemia prevalence in the 2-9 year old group was evident in both treatment arms, but in the 10-25 year old group the reduction was only 16.8% in the 2-drug arm. Our results suggest that the annual, single-dose combination (DEC + ALB) mass treatment regimen has an enhanced effect against bancroftian filariasis compared to single-drug therapy.
- Published
- 2004
- Full Text
- View/download PDF
11. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
- Author
-
Rajendran R, Mani TR, Munirathinam A, Sunish IP, Abdullah SM, Augustin DJ, and Satyanarayana K
- Subjects
- Animals, Child, Drug Administration Schedule, Drug Combinations, Elephantiasis, Filarial epidemiology, Elephantiasis, Filarial parasitology, Elephantiasis, Filarial transmission, Feces parasitology, Female, Humans, India epidemiology, Male, Parasite Egg Count, Prevalence, Program Evaluation, Treatment Outcome, Albendazole therapeutic use, Diethylcarbamazine therapeutic use, Elephantiasis, Filarial prevention & control, Filaricides therapeutic use, Soil parasitology
- Abstract
We evaluated the long-term impact of single-dose diethylcarbamazine plus albendazole combination therapy with that of diethylcarbamazine alone on the control of soil-transmitted helminths (STH) in 2 blocks (revenue units) of Villupuram district, south India, as part of an ongoing mass drug administration (MDA) campaign for the elimination of lymphatic filariasis in 2001. The prevalence and intensities of STHs were studied in 287 children, aged 9 and 10 years (136 in the combination therapy cohort and 151 in the diethylcarbamazine alone cohort), using the Kato-Katz technique to examine stool samples at 4 time-points (baseline, and 3 weeks, 6 months and 11 months after MDA). The combination therapy showed long-term efficacy against STHs and the magnitude of control remained at a moderate and significant level for 11 months after MDA compared with the moderate gains of diethylcarbamazine alone. Single-dose MDA with albendazole and diethylcarbamazine combination therapy may prove to be a good strategy in treating multiple parasitic infections in endemic communities.
- Published
- 2003
- Full Text
- View/download PDF
12. Targeting of children in filariasis mass drug administration.
- Author
-
Rajendran R, Sunish IP, Mani TR, Munirathinam A, and Satyanarayana K
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Elephantiasis, Filarial epidemiology, Humans, India epidemiology, Albendazole therapeutic use, Anthelmintics therapeutic use, Diethylcarbamazine therapeutic use, Elephantiasis, Filarial drug therapy
- Published
- 2002
- Full Text
- View/download PDF
13. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
- Author
-
Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, and Satyanarayana K
- Subjects
- Adolescent, Adult, Animals, Antigens, Helminth blood, Child, Child, Preschool, Cross-Sectional Studies, Drug Therapy, Combination, Female, Filariasis epidemiology, Follow-Up Studies, Humans, India epidemiology, Male, Patient Compliance, Prevalence, Treatment Outcome, Albendazole therapeutic use, Diethylcarbamazine therapeutic use, Filariasis drug therapy, Filaricides therapeutic use, Wuchereria bancrofti immunology
- Abstract
The current Indian campaign for the elimination of lymphatic filariasis is largely based on mass drug administration (MDA). As part of this campaign, villagers in the Tirukoilur and Mugaiyur 'blocks' (i.e. revenue units) of Villupuram district, in Tamil Nadu, India, were treated with diethylcarbamazine (DEC), either alone (Mugaiyur) or with albendazole (Tirukoilur), in March 2001. The efficacy of treatment, in each of the two treatment arms, was evaluated by determining the percentages of the subjects who were carrying antigen from adult Wuchereria bancrofti before, 6 months and 12 months after the MDA. In a cross-sectional survey at each time-point, commercial, immunochromatographic tests were used to check 1000-1200, randomly selected, young residents (aged 2-25 years) of 18 index villages for the antigen; at least 300 villagers aged 2-9 years and at least 170 aged 10-25 years from each treatment arm were screened in each survey. Before the MDA, 12.7% of the subjects aged 2-9 years and 23.6% of those aged 10-25 years were found to be positive for the filarial antigen. Although only about 50% of villagers aged 2-9 years were successfully treated, MDA (with DEC alone or DEC plus albendazole) led to a significant (28.7%) reduction in the prevalence of antigenaemia in this age-group 6 months later (P<0.05). Although, the prevalences of antigenaemia among those aged 2-9 years were higher 12 months post-treatment than 6 months post-treatment, they were still lower (by 16%-23%) than those observed pre-treatment. The addition of albendazole to the DEC treatment appeared to offer no additional benefit in terms of the prevalence of antigenaemia in children aged <10 years; in fact, the use of DEC alone produced a slightly greater reduction in the prevalence of antigenaemia than the use of both DEC and albendazole. In the block given MDA based on both DEC and albendazole, the prevalences of antigenaemia among the villagers aged 10-25 years were 19.4% and 16.6% lower 6 and 12 months post-treatment, respectively, than observed pre-treatment. Curiously, in the block given DEC alone, the prevalences in this age-group were higher at both post-treatment follow-ups (by 17.4% at 6 months and 35.1% at 12 months) than observed pre-treatment. In concurrent experimental studies, high drug compliance (90%) among young children (aged 2-5 years) led to a pronounced (62.6%) reduction in the prevalence of antigenaemia after one MDA. In follow-up studies of those found antigen-positive, 40% of those aged 2-9 years but only 23% of those aged 10-25 years cleared their antigenaemias after three (annual) MDA. To maximize the benefits of MDA, greater efforts should be made to increase treatment coverage among young children.
- Published
- 2002
- Full Text
- View/download PDF
14. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India.
- Author
-
Mani TR, Rajendran R, Munirathinam A, Sunish IP, Md Abdullah S, Augustin DJ, and Satyanarayana K
- Subjects
- Adolescent, Ascariasis drug therapy, Ascariasis epidemiology, Child, Child, Preschool, Cross-Sectional Studies, Drug Combinations, Female, Helminthiasis epidemiology, Helminthiasis prevention & control, Humans, India epidemiology, Infant, Male, Parasite Egg Count, Prevalence, Treatment Outcome, Trichuriasis drug therapy, Trichuriasis epidemiology, Albendazole therapeutic use, Anthelmintics therapeutic use, Diethylcarbamazine therapeutic use, Filaricides therapeutic use, Helminthiasis drug therapy
- Abstract
The efficacy of single-dose combination drug therapy with diethylcarbamazine (DEC) plus albendazole (ALB), and single-drug therapy with DEC alone against geohelminths was compared as part of a mass drug administration (MDA) for elimination of filariasis. This study was conducted in two blocks of Villupuram District of Tamil Nadu State, India, covering a population of 321 000 including about 100 000 children 1-15 years of age. Prevalence and intensity of geohelminth infection were determined by the Kato-Katz technique immediately before and 3 weeks after the MDA. A pre-treatment cross-sectional survey was undertaken in 18 statistically selected villages out of 204 villages, including 646 school children. About 60% were infected with one or more geohelminths. The overall prevalence rates were 53.9%, 12.4% and 5.7% for Ascaris lumbricoides, hookworms and Trichuris trichiura, respectively. Combination therapy (DEC + ALB) produced a cure rate of 74.3% and an egg reduction rate of 97.3% for geohelminths, which were higher than the corresponding rates (30.4% and 79.0%) observed in the single drug therapy arm with DEC alone. The odds of cure with combination therapy were significantly higher for roundworm (5.3 times) and hookworms (3.5 times), then odds of cure with DEC alone. Both therapies were equally effective against trichuriasis, recording cure rates >77% and egg reduction rates >83%. In combination therapy, 53.5% of the children noticed expulsion of worms after MDA, while in single drug therapy only 20.9% did. Our study indicated that MDA of combination therapy was operationally feasible at the community level, and it may secure higher community compliance because of its perceived benefits and enhanced efficacy against geohelminths than single-drug therapy.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.